-
1
-
-
0035142836
-
Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis
-
COI: 1:CAS:528:DC%2BD3MXlt1Kquw%3D%3D
-
Miettinen M, Lasota J. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Archiv: an international journal of pathology 2001;438(1): 1–12.
-
(2001)
Virchows Archiv : an international journal of pathology
, vol.438
, Issue.1
, pp. 1-12
-
-
Miettinen, M.1
Lasota, J.2
-
2
-
-
13444270334
-
Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden
-
PID: 15648083
-
Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden. Cancer 2005;103(4): 821–829.
-
(2005)
Cancer
, vol.103
, Issue.4
, pp. 821-829
-
-
Nilsson, B.1
Bumming, P.2
Meis-Kindblom, J.M.3
Oden, A.4
Dortok, A.5
Gustavsson, B.6
Sablinska, K.7
Kindblom, L.G.8
-
3
-
-
25444448316
-
Gastrointestinal stromal tumors in Iceland, 1990–2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study
-
COI: 1:CAS:528:DC%2BD2MXhtVygsrfO, PID: 15900576
-
Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG. Gastrointestinal stromal tumors in Iceland, 1990–2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. International journal of cancer Journal international du cancer 2005;117(2): 289–293.
-
(2005)
International journal of cancer Journal international du cancer
, vol.117
, Issue.2
, pp. 289-293
-
-
Tryggvason, G.1
Gislason, H.G.2
Magnusson, M.K.3
Jonasson, J.G.4
-
4
-
-
67650837935
-
An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system
-
PID: 19620548
-
Woodall CE, 3rd, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, Martin RC, 2nd. An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Archives of surgery 2009;144(7): 670–678.
-
(2009)
Archives of surgery
, vol.144
, Issue.7
, pp. 670-678
-
-
Woodall, C.E.1
Brock, G.N.2
Fan, J.3
Byam, J.A.4
Scoggins, C.R.5
McMasters, K.M.6
Martin, R.C.7
-
6
-
-
78049483265
-
Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour
-
COI: 1:STN:280:DC%2BC3cbltF2nsA%3D%3D, PID: 20730857
-
Hohenberger P, Ronellenfitsch U, Oladeji O, Pink D, Strobel P, Wardelmann E, Reichardt P. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. The British journal of surgery 2010;97(12): 1854–1859.
-
(2010)
The British journal of surgery
, vol.97
, Issue.12
, pp. 1854-1859
-
-
Hohenberger, P.1
Ronellenfitsch, U.2
Oladeji, O.3
Pink, D.4
Strobel, P.5
Wardelmann, E.6
Reichardt, P.7
-
7
-
-
84857502045
-
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
-
PID: 22153892
-
Joensuu H, Vehtari A, Riihimaki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. The lancet oncology 2012;13(3): 265–274.
-
(2012)
The lancet oncology
, vol.13
, Issue.3
, pp. 265-274
-
-
Joensuu, H.1
Vehtari, A.2
Riihimaki, J.3
Nishida, T.4
Steigen, S.E.5
Brabec, P.6
Plank, L.7
Nilsson, B.8
Cirilli, C.9
Braconi, C.10
Bordoni, A.11
Magnusson, M.K.12
Linke, Z.13
Sufliarsky, J.14
Federico, M.15
Jonasson, J.G.16
Dei Tos, A.P.17
Rutkowski, P.18
-
8
-
-
38749149936
-
Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
-
PID: 18076015
-
Dematteo RP, Gold JS, Saran L, Gonen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 2008;112(3): 608–615.
-
(2008)
Cancer
, vol.112
, Issue.3
, pp. 608-615
-
-
Dematteo, R.P.1
Gold, J.S.2
Saran, L.3
Gonen, M.4
Liau, K.H.5
Maki, R.G.6
Singer, S.7
Besmer, P.8
Brennan, M.F.9
Antonescu, C.R.10
-
9
-
-
50649085726
-
Risk stratification of patients diagnosed with gastrointestinal stromal tumor
-
PID: 18774375
-
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Human pathology 2008;39(10): 1411–1419.
-
(2008)
Human pathology
, vol.39
, Issue.10
, pp. 1411-1419
-
-
Joensuu, H.1
-
10
-
-
33646685694
-
Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up
-
PID: 16625094
-
Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. The American journal of surgical pathology 2006;30(4): 477–489.
-
(2006)
The American journal of surgical pathology
, vol.30
, Issue.4
, pp. 477-489
-
-
Miettinen, M.1
Makhlouf, H.2
Sobin, L.H.3
Lasota, J.4
-
11
-
-
11144284051
-
Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up
-
PID: 15613856
-
Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. The American journal of surgical pathology 2005;29(1): 52–68.
-
(2005)
The American journal of surgical pathology
, vol.29
, Issue.1
, pp. 52-68
-
-
Miettinen, M.1
Sobin, L.H.2
Lasota, J.3
-
12
-
-
81855226071
-
Gastrointestinal stromal tumours: origin and molecular oncology
-
COI: 1:CAS:528:DC%2BC3MXhsVOisb3I, PID: 22089421
-
Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nature reviews Cancer 2011;11(12): 865–878.
-
(2011)
Nature reviews Cancer
, vol.11
, Issue.12
, pp. 865-878
-
-
Corless, C.L.1
Barnett, C.M.2
Heinrich, M.C.3
-
13
-
-
62849096370
-
American College of Surgeons Oncology Group Intergroup Adjuvant GST. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
-
COI: 1:CAS:528:DC%2BD1MXjslOltro%3D, PID: 19303137
-
Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K, American College of Surgeons Oncology Group Intergroup Adjuvant GST. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 2009;373(9669): 1097–1104.
-
(2009)
Lancet
, vol.373
, Issue.9669
, pp. 1097-1104
-
-
Dematteo, R.P.1
Ballman, K.V.2
Antonescu, C.R.3
Maki, R.G.4
Pisters, P.W.5
Demetri, G.D.6
Blackstein, M.E.7
Blanke, C.D.8
von Mehren, M.9
Brennan, M.F.10
Patel, S.11
McCarter, M.D.12
Polikoff, J.A.13
Tan, B.R.14
Owzar, K.15
-
14
-
-
84859187987
-
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
-
COI: 1:CAS:528:DC%2BC38XltVCks78%3D
-
Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schutte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Monge OR, Bono P, Kallio R, Vehtari A, Leinonen M, Alvegard T, Reichardt P. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA: the journal of the American Medical Association 2012;307(12): 1265–1272.
-
(2012)
JAMA : the journal of the American Medical Association
, vol.307
, Issue.12
, pp. 1265-1272
-
-
Joensuu, H.1
Eriksson, M.2
Sundby Hall, K.3
Hartmann, J.T.4
Pink, D.5
Schutte, J.6
Ramadori, G.7
Hohenberger, P.8
Duyster, J.9
Al-Batran, S.E.10
Schlemmer, M.11
Bauer, S.12
Wardelmann, E.13
Sarlomo-Rikala, M.14
Nilsson, B.15
Sihto, H.16
Monge, O.R.17
Bono, P.18
Kallio, R.19
Vehtari, A.20
Leinonen, M.21
Alvegard, T.22
Reichardt, P.23
more..
-
15
-
-
0036301722
-
Diagnosis of gastrointestinal stromal tumors: A consensus approach
-
PID: 12094370
-
Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Human pathology 2002;33(5): 459–465.
-
(2002)
Human pathology
, vol.33
, Issue.5
, pp. 459-465
-
-
Fletcher, C.D.1
Berman, J.J.2
Corless, C.3
Gorstein, F.4
Lasota, J.5
Longley, B.J.6
Miettinen, M.7
O'Leary, T.J.8
Remotti, H.9
Rubin, B.P.10
Shmookler, B.11
Sobin, L.H.12
Weiss, S.W.13
-
16
-
-
71449088757
-
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
-
PID: 19793678
-
Gold JS, Gonen M, Gutierrez A, Broto JM, Garcia-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. The lancet oncology 2009;10(11): 1045–1052.
-
(2009)
The lancet oncology
, vol.10
, Issue.11
, pp. 1045-1052
-
-
Gold, J.S.1
Gonen, M.2
Gutierrez, A.3
Broto, J.M.4
Garcia-del-Muro, X.5
Smyrk, T.C.6
Maki, R.G.7
Singer, S.8
Brennan, M.F.9
Antonescu, C.R.10
Donohue, J.H.11
DeMatteo, R.P.12
-
17
-
-
33750618188
-
Gastrointestinal stromal tumors: pathology and prognosis at different sites
-
PID: 17193820
-
Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Seminars in diagnostic pathology 2006;23(2): 70–83.
-
(2006)
Seminars in diagnostic pathology
, vol.23
, Issue.2
, pp. 70-83
-
-
Miettinen, M.1
Lasota, J.2
-
18
-
-
33845382806
-
Nonparametric-Estimation from Incomplete Observations
-
Kaplan EL, Meier P. Nonparametric-Estimation from Incomplete Observations. J Am Stat Assoc 1958;53(282): 457–481.
-
(1958)
J Am Stat Assoc
, vol.53
, Issue.282
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
19
-
-
0000336139
-
Regression Models and Life-Tables
-
Cox DR. Regression Models and Life-Tables. J Roy Stat Soc B 1972;34(2): 187–220.
-
(1972)
J Roy Stat Soc B
, vol.34
, Issue.2
, pp. 187-220
-
-
Cox, D.R.1
-
21
-
-
0030069896
-
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
-
PID: 8668867
-
Harrell FE, Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in medicine 1996;15(4): 361–387.
-
(1996)
Statistics in medicine
, vol.15
, Issue.4
, pp. 361-387
-
-
Harrell, F.E.1
Lee, K.L.2
Mark, D.B.3
-
22
-
-
34247610583
-
Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor
-
PID: 17435539
-
DeMatteo RP, Maki RG, Singer S, Gonen M, Brennan MF, Antonescu CR. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Annals of surgery 2007;245(3): 347–352.
-
(2007)
Annals of surgery
, vol.245
, Issue.3
, pp. 347-352
-
-
DeMatteo, R.P.1
Maki, R.G.2
Singer, S.3
Gonen, M.4
Brennan, M.F.5
Antonescu, C.R.6
-
23
-
-
84911990842
-
Risk of Recurrence After Resection of Primary GIST: Available Tools Compared and Contrasted
-
Gold JS. Risk of Recurrence After Resection of Primary GIST: Available Tools Compared and Contrasted. The GIST Cancer Journal 2014;1(1): 20–23.
-
(2014)
The GIST Cancer Journal
, vol.1
, Issue.1
, pp. 20-23
-
-
Gold, J.S.1
-
24
-
-
33746401591
-
Australasian GastroIntestinal Trials G. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours
-
COI: 1:CAS:528:DC%2BD28Xks1ertb0%3D, PID: 16624552
-
Debiec-Rychter M, Sciot R, Le Cesne A, Schlemmer M, Hohenberger P, van Oosterom AT, Blay JY, Leyvraz S, Stul M, Casali PG, Zalcberg J, Verweij J, Van Glabbeke M, Hagemeijer A, Judson I, Tissue ES, Bone Sarcoma G, Italian Sarcoma G, Australasian GastroIntestinal Trials G. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. European journal of cancer 2006;42(8): 1093–1103.
-
(2006)
European journal of cancer
, vol.42
, Issue.8
, pp. 1093-1103
-
-
Debiec-Rychter, M.1
Sciot, R.2
Le Cesne, A.3
Schlemmer, M.4
Hohenberger, P.5
van Oosterom, A.T.6
Blay, J.Y.7
Leyvraz, S.8
Stul, M.9
Casali, P.G.10
Zalcberg, J.11
Verweij, J.12
Van Glabbeke, M.13
Hagemeijer, A.14
Judson, I.15
Tissue, E.S.16
Bone Sarcoma, G.17
Italian Sarcoma, G.18
-
25
-
-
56749156604
-
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
-
COI: 1:CAS:528:DC%2BD1MXhslCmug%3D%3D
-
Heinrich MC, Owzar K, Corless CL, Hollis D, Borden EC, Fletcher CD, Ryan CW, von Mehren M, Blanke CD, Rankin C, Benjamin RS, Bramwell VH, Demetri GD, Bertagnolli MM, Fletcher JA. Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008;26(33): 5360–5367.
-
(2008)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
, vol.26
, Issue.33
, pp. 5360-5367
-
-
Heinrich, M.C.1
Owzar, K.2
Corless, C.L.3
Hollis, D.4
Borden, E.C.5
Fletcher, C.D.6
Ryan, C.W.7
von Mehren, M.8
Blanke, C.D.9
Rankin, C.10
Benjamin, R.S.11
Bramwell, V.H.12
Demetri, G.D.13
Bertagnolli, M.M.14
Fletcher, J.A.15
-
26
-
-
24944536236
-
Deletions affecting codons 557–558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS)
-
Spanish Group for Sarcoma R, COI: 1:CAS:528:DC%2BD2MXhtVKgtbrO
-
Martin J, Poveda A, Llombart-Bosch A, Ramos R, Lopez-Guerrero JA, Garcia del Muro J, Maurel J, Calabuig S, Gutierrez A, Gonzalez de Sande JL, Martinez J, De Juan A, Lainez N, Losa F, Alija V, Escudero P, Casado A, Garcia P, Blanco R, Buesa JM, Spanish Group for Sarcoma R. Deletions affecting codons 557–558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2005;23(25): 6190–6198.
-
(2005)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
, vol.23
, Issue.25
, pp. 6190-6198
-
-
Martin, J.1
Poveda, A.2
Llombart-Bosch, A.3
Ramos, R.4
Lopez-Guerrero, J.A.5
Garcia del Muro, J.6
Maurel, J.7
Calabuig, S.8
Gutierrez, A.9
Gonzalez de Sande, J.L.10
Martinez, J.11
De Juan, A.12
Lainez, N.13
Losa, F.14
Alija, V.15
Escudero, P.16
Casado, A.17
Garcia, P.18
Blanco, R.19
Buesa, J.M.20
more..
|